| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3901084 | Urology | 2011 | 7 Pages |
Abstract
Our results have demonstrated that phosphorylation of cortactin is a key process in malignant aggressiveness, and its expression is a useful predictor of cause-specific survival and could be a useful potential therapeutic target in patients with SRCC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Tomohiro Matsuo, Yasuyoshi Miyata, Shin-Ichi Watanabe, Kojiro Ohba, Tomayoshi Hayashi, Shigeru Kanda, Hideki Sakai,